Elantas Beck to spend ₹56 cr on a 31% capacity boost at Ankleshwar
The specialty chemicals maker is funding the expansion from internal accruals and expects a 12-month build-out.
What's new
- Board approved a ₹56 cr expansion to add 11,000 MT/year of capacity at Ankleshwar, a 31% increase.
- The project will be funded entirely from internal accruals.
- The company targets completion within 12 months.
Why this matters
This is the company's largest capacity addition in recent years, using its own cash. For a firm with ₹848 crore in annual revenue, deploying 6.6% of sales on a single plant bet signals management has order visibility or firm client commitments to absorb the new volumes.
What we're watching
- Whether the new capacity is for specific products or serves as general buffer stock.
- The plant's ramp-up timeline and initial utilization rates post-commissioning.
- How the ₹56 crore outlay affects free cash flow in FY26 and FY27.
The full read
Elantas Beck is putting ₹56 crore into its Ankleshwar plant, a bet that demand for its specialty chemicals can absorb an immediate 31% jump in capacity. The new 11,000 MT/year of output will bring the plant's total to 35,000 MT/year. Management's choice to fund the build entirely from internal accruals is the signal: for a company with ₹848 crore in annual revenue, this is a 6.6% of sales commitment made without taking on debt. The 12-month completion target is aggressive for this scale. The open question is which product segments are pulling this capacity forward, and whether the volumes are already contracted.
Questions answered
- How big is this expansion relative to Elantas Beck's existing capacity?
- The Ankleshwar plant currently has a capacity of 35,000 MT/year. Adding 11,000 MT/year increases the facility's total volume potential by about 31%.
- How is the expansion being paid for?
- The entire ₹56 crore investment will be funded from the company's internal accruals, with no external debt or equity raising planned for the project.
- What is the project's timeline?
- The company expects the new capacity to be operational within 12 months from the date of the board approval.
- What does the investment represent in terms of company scale?
- For a company with annual revenue of about ₹848 crore, the ₹56 crore capex equals roughly 6.6% of its annual sales, making it a significant allocation of capital.